itragerm 50 mg capsulas duras
isdin s.a. - itraconazol - cÁpsula dura - 50 mg - itraconazol 50 mg - itraconazol
mysoline 250 mg comprimidos
serb - primidona - comprimido - 250 mg - primidona 250 mg - primidona
sporanox 100 mg capsulas
janssen cilag s.a. - itraconazol - cÁpsula dura - 100 mg - itraconazol 100 mg - itraconazol
itraconazol 100 mg capsula
laboratorios ac farma s.a. - itraconazol; - capsula - por capsula - itraconazol
olumiant 2mg comprimido recubierto
tecnofarma s.a. - droguerÍa - comprimido recubierto - por comprimido - - baricitinib
olumiant 4 mg comprimido recubierto
eli lilly interamerica inc. sucursal peruana - comprimido recubierto - por comprimido - baricitinib
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - agentes antineoplásicos - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.